A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
HiFiBiO Therapeutics
Pfizer
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
University of California, San Francisco
Incyte Corporation
Incyte Corporation
Sotio Biotech Inc.
Molecular Templates, Inc.
Atreca, Inc.
University of Florida
Fate Therapeutics
Children's National Research Institute
Apollomics (Australia) Pty. Ltd.
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AbbVie
Masonic Cancer Center, University of Minnesota
Mirna Therapeutics, Inc.
Dartmouth-Hitchcock Medical Center
University Hospital, Bordeaux